|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.37 USD | +4.32% |
|
+8.82% | +41.27% |
| 06-30 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell 2500 Growth Benchmark | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 41.64 | 45.58 | 42.56 |
| Spread/Res. | -7.85% | -15.82% | -9.84% |
| Spread/Supp. | +16.34% | +34.35% | +34.07% |
| Support | 32.98 | 28.56 | 28.62 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CLDX Stock
- Charts Celldex Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
